Ortin Laboratories Ltd Financials
Company Logo

Ortin Laboratories Ltd Financial Statement

Ortin Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue0.21
Operating Expense0.31
Net Profit-0.10
Net Profit Margin-47.62
Earning Per Share-0.13
EBIDTA-0.10
Effective Tax RateTBA

Ortin Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual2.11
Operating Expenses Annual8.65
Operating Profit Annual-6.36
Interest Annual0.48
Depreciation0.23
Net Profit Annual-8.04
Tax Annual0.97

Ortin Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning-3.26
Cash Flow from Operations-4.79
Cash Flow from Investing12
Cash Flow from Financing-3.49
Cash Flow at the End0.46

Ortin Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)-200
PBIT Margin (%)-210.90
PBT Margin (%)227.49
Net PROFIT Margin (%)-381.04
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-72.40
Total Debt / Equity (X)0.60
Asset Turnover Ratio (%)0.19

Ortin Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.01
Total Current Assets Annual6.34
Non Current Assets Annual0.32
Total Shareholders Funds Annual2.82
Total Assets Annual6.66

Ortin Laboratories Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Sep 19, 2024, Ortin Laboratories Ltd has a market capitalization of 14.47 Cr. Value Research classifies it as a Micro-Cap company.
No, Ortin Laboratories Ltd is not debt-free with a debt-to-equity ratio of 0.64.
In FY 2023 , Ortin Laboratories Ltd recorded a total revenue of approximately 2.11 Cr marking a significant milestone in the company's financial performance.
Ortin Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and -0.7% annually, respectively..
Ortin Laboratories Ltd's current PE ratio is -1.80.
Ortin Laboratories Ltd's ROCE averaged -46.4% from the FY ending March 2022 to 2024, with a median of 1.6%. It peaked at 1.8% in March 2023, reflecting strong capital efficiency over the period..
Ortin Laboratories Ltd's latest EBIT is Rs. -6.60 Cr, surpassing the average EBIT of Rs. -2.01 Cr over the 5 years..